Tekla Capital Management LLC Morphic Holding, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022
BUY
$19.74 - $43.01 $189,503 - $412,896
9,600 Added 27.41%
44,625 $968,000
Q3 2021

Nov 12, 2021
BUY
$53.61 - $67.5 $1.88 Million - $2.36 Million
35,025 New
35,025 $1.98 Million
Q2 2021

Aug 13, 2021
SELL
$45.13 - $64.99 $4.04 Million - $5.82 Million
-89,559 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$29.77 - $84.85 $2.67 Million - $7.6 Million
89,559 New
89,559 $5.67 Million

Others Institutions Holding MORF

# of Institutions
140
Shares Held
38.7M
Call Options Held
4.2K
Put Options Held
200K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email